Abstract
Heart transplant (HTx) is the treatment of choice in Chagasic advanced heart failure. CsA is the main immunosuppressant reported, but there is lack of information about of Tacrolimus use in this patient (p) group. Our aim was to analyze early and long term outcomes in Chagasic HTx p, comparing two different de novo immunosuppressive strategies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
